Geriatric nutritional risk index predicts postoperative outcomes in elderly patients with pancreatoduodenectomy: a propensity score-matched analysis

老年营养风险指数预测老年胰十二指肠切除术后患者的预后:一项倾向评分匹配分析

阅读:3

Abstract

BACKGROUND: The Geriatric Nutrition Risk Index (GNRI) serves as a straightforward screening tool for predicting the likelihood of postoperative complications and mortality in elderly patients. This study aimed to investigate the association between GNRI and postoperative outcomes in elderly patients undergoing pancreaticoduodenectomy (PD). METHODS: We enrolled patients aged 65 years or older who underwent PD between January 2018 and March 2023. Patients were dichotomized into at-risk (GNRI ≤98) or no-risk (GNRI >98) groups. Propensity score matching was used to compare the baseline differences and postoperative outcomes between these two groups. Logistic regression analysis was conducted to assess the association between GNRI and major morbidity (Clavien-Dindo scale with ≥ grade 3b complications). RESULTS: There were 392 eligible patients included. Following propensity score matching, patients in the at-risk GNRI group had higher rates of major complication (13.2% vs. 5.4%, P=0.03) and pulmonary infection (17.8% vs. 9.3%, P=0.046). Based on the multivariate analysis, at-risk group was an independent prognostic factor for major morbidity (odds ratio =2.698, 95% CI: 1.062-6.856, P=0.04). Subgroup analysis revealed that high-risk patients (GNRI <82) exhibited higher rates of preoperative jaundice and longer operative time in comparison to the moderate (GNRI =82-91) and low-risk (GNRI =92-98) groups. However, there were no statistically significant disparities in morbidity and mortality among these three groups. CONCLUSIONS: We demonstrated that nutritional status evaluated by GNRI predicts postoperative complications after PD in elderly patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。